Active — Not RecruitingNot Applicable

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

United States200 participantsStarted 2024-01-18

Plain-language summary

This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.

Who can participate

Age range2 Years – 20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Males and females age 2-20 years with suspicion of MASLD or presenting to liver clinic for evaluation of liver disease, including possible MASLD * For participants choosing to do MRI they have to be able to undergo MRI without sedation * Written/verbal informed consent from parent or legal guardian * Written/verbal informed assent from the child when indicated by age Exclusion Criteria: * Ascites * Pregnancy * Failure to give consent or assent * Have an implanted electronic device such as pacemaker, neurostimulator, or cochlear implant